← Back to home

HPV-mediated (P16-positive) oropharyngeal carcinoma by ajcc V8 clinical stage

Clinical trials for HPV-mediated (P16-positive) oropharyngeal carcinoma by ajcc V8 clinical stage explained in plain language.

Never miss a new study

Get alerted when new HPV-mediated (P16-positive) oropharyngeal carcinoma by ajcc V8 clinical stage trials appear

Sign up with your email to follow new studies for HPV-mediated (P16-positive) oropharyngeal carcinoma by ajcc V8 clinical stage, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Blood test may tailor throat cancer treatment, sparing patients from harsh side effects

Disease control Recruiting now

This trial tests whether a blood test that detects HPV DNA can help doctors personalize treatment for people with HPV-related throat cancer. Participants receive radiation therapy, with or without chemotherapy, but the intensity is adjusted based on their blood test results and c…

Matched conditions: HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA BY AJCC V8 CLINICAL STAGE

Phase 2 • Sponsor: Jonathan Schoenfeld, MD, MPH • Aim: Disease control

Last updated Aug 07, 2026 00:00 UTC

HPV-mediated (P16-positive) oropharyngeal carcinoma by ajcc V8 clinical stage

Get alerted when new HPV-mediated (P16-positive) oropharyngeal carcinoma by ajcc V8 clinical stage trials appear

Blood test may tailor throat cancer treatment, sparing patients from harsh side effects